StockData
Progyny, Inc. logo

Progyny, Inc. (PGNY) stock

PGNYNasdaqServices-Misc Health & Allied Services, NECFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 19/304% above fair value
$36.16−0.55 (-1.50%)

Close on Nov 18, 2026Market cap $2.77BP/E 39.3Yield –

Progyny revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Progyny's revenue for the twelve months ending Jun 30, 2026 was $1.31B, up 5.5% year over year. For fiscal 2025 it was $1.29B, up 10.4% from the year before. The highest annual figure on record is $1.29B in fiscal 2025.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$1.29B+10.4%
FY2024Dec 31, 2024$1.17B+7.2%
FY2023Dec 31, 2023$1.09B+38.3%
FY2022Dec 31, 2022$786.91M+57.2%
FY2021Dec 31, 2021$500.62M+45.2%
FY2020Dec 31, 2020$344.86M+50.1%
FY2019Dec 31, 2019$229.68M+117.9%
FY2018Dec 31, 2018$105.40M+116.9%
FY2017Dec 31, 2017$48.58M–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$350.51M+5.3%
Q1 FY2026Mar 31, 2026$328.50M+1.4%
Q4 FY2025Dec 31, 2025$318.40M+6.7%
Q3 FY2025Sep 30, 2025$313.35M+9.3%
Q2 FY2025Jun 30, 2025$332.87M+9.5%
Q1 FY2025Mar 31, 2025$324.04M+16.5%
Q4 FY2024Dec 31, 2024$298.43M+10.6%
Q3 FY2024Sep 30, 2024$286.63M+2.0%
Q2 FY2024Jun 30, 2024$304.09M+8.8%
Q1 FY2024Mar 31, 2024$278.08M+7.6%
Q4 FY2023Dec 31, 2023$269.94M+26.0%
Q3 FY2023Sep 30, 2023$280.89M+36.8%
Q2 FY2023Jun 30, 2023$279.37M+43.3%
Q1 FY2023Mar 31, 2023$258.39M+50.0%
Q4 FY2022Dec 31, 2022$214.32M+68.0%
Q3 FY2022Sep 30, 2022$205.37M+67.9%
Q2 FY2022Jun 30, 2022$195.00M+51.6%
Q1 FY2022Mar 31, 2022$172.22M+41.0%
Q4 FY2021Dec 31, 2021$127.55M+27.2%
Q3 FY2021Sep 30, 2021$122.28M+23.6%
Q2 FY2021Jun 30, 2021$128.65M+99.1%
Q1 FY2021Mar 31, 2021$122.13M+50.7%
Q4 FY2020Dec 31, 2020$100.30M+54.0%
Q3 FY2020Sep 30, 2020$98.93M+61.7%
Q2 FY2020Jun 30, 2020$64.61M+15.0%
Q1 FY2020Mar 31, 2020$81.02M+71.7%
Q4 FY2019Dec 31, 2019$65.12M+123.1%
Q3 FY2019Sep 30, 2019$61.20M+120.1%
Q2 FY2019Jun 30, 2019$56.17M+114.7%
Q1 FY2019Mar 31, 2019$47.20M+112.0%
Q4 FY2018Dec 31, 2018$29.19M–
Q3 FY2018Sep 30, 2018$27.80M–
Q2 FY2018Jun 30, 2018$26.16M–
Q1 FY2018Mar 31, 2018$22.26M–

More Progyny figures

See a number that looks wrong?